Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Barney S Graham

Showing results (31-40 of 420) with videos related to

Pageof 42
Sort By:
The Journal of Infectious Diseases|December 7, 2016
Chikungunya in the Americas: Recommendations and ConclusionsBarney S Graham, Patricia M Repik, Sergio Yactayo
Scientific Reports|September 30, 2016
Pre-fusion F is absent on the surface of formalin-inactivated respiratory syncytial virusApril M Killikelly, Masaru Kanekiyo, Barney S Graham
Antimicrobial Agents and Chemotherapy|October 25, 2003
Antiviral activity of RhoA-derived peptides against respiratory syncytial virus is dependent on formation of peptide dimersPhilip J Budge, Jacob Lebowitz, Barney S Graham
Viral Immunology|May 3, 2003
The complex relationship between respiratory syncytial virus and allergy in lung diseaseR Stokes Peebles, Koichi Hashimoto, Barney S Graham
Current Opinion in Immunology|June 13, 2015
Novel antigens for RSV vaccinesBarney S Graham, Kayvon Modjarrad, Jason S McLellan
Current Topics in Microbiology and Immunology|December 24, 2013
Respiratory syncytial virus: virology, reverse genetics, and pathogenesis of diseasePeter L Collins, Rachel Fearns, Barney S Graham
Journal of Virology|November 18, 2011
Respiratory syncytial virus glycoprotein G interacts with DC-SIGN and L-SIGN to activate ERK1 and ERK2Teresa R Johnson, Jason S McLellan, Barney S Graham
The Journal of General Virology|August 22, 2001
Construction and characterization of recombinant vaccinia viruses co-expressing a respiratory syncytial virus protein and a cytokineTeresa R Johnson, Julie E Fischer, Barney S Graham
The New England Journal of Medicine|August 20, 2020
A SARS-CoV-2 mRNA Vaccine - Preliminary Report. ReplyLisa A Jackson, Paul C Roberts, Barney S Graham
JAMA|March 23, 2018
Novel Vaccine Technologies: Essential Components of an Adequate Response to Emerging Viral DiseasesBarney S Graham, John R Mascola, Anthony S Fauci
Pageof 42

Showing results (31-40 of 420) with videos related to

Sort By:
Pageof 42
The Journal of Infectious Diseases|December 7, 2016
Chikungunya in the Americas: Recommendations and ConclusionsBarney S Graham, Patricia M Repik, Sergio Yactayo
Scientific Reports|September 30, 2016
Pre-fusion F is absent on the surface of formalin-inactivated respiratory syncytial virusApril M Killikelly, Masaru Kanekiyo, Barney S Graham
Antimicrobial Agents and Chemotherapy|October 25, 2003
Antiviral activity of RhoA-derived peptides against respiratory syncytial virus is dependent on formation of peptide dimersPhilip J Budge, Jacob Lebowitz, Barney S Graham
Viral Immunology|May 3, 2003
The complex relationship between respiratory syncytial virus and allergy in lung diseaseR Stokes Peebles, Koichi Hashimoto, Barney S Graham
Current Opinion in Immunology|June 13, 2015
Novel antigens for RSV vaccinesBarney S Graham, Kayvon Modjarrad, Jason S McLellan
Current Topics in Microbiology and Immunology|December 24, 2013
Respiratory syncytial virus: virology, reverse genetics, and pathogenesis of diseasePeter L Collins, Rachel Fearns, Barney S Graham
Journal of Virology|November 18, 2011
Respiratory syncytial virus glycoprotein G interacts with DC-SIGN and L-SIGN to activate ERK1 and ERK2Teresa R Johnson, Jason S McLellan, Barney S Graham
The Journal of General Virology|August 22, 2001
Construction and characterization of recombinant vaccinia viruses co-expressing a respiratory syncytial virus protein and a cytokineTeresa R Johnson, Julie E Fischer, Barney S Graham
The New England Journal of Medicine|August 20, 2020
A SARS-CoV-2 mRNA Vaccine - Preliminary Report. ReplyLisa A Jackson, Paul C Roberts, Barney S Graham
JAMA|March 23, 2018
Novel Vaccine Technologies: Essential Components of an Adequate Response to Emerging Viral DiseasesBarney S Graham, John R Mascola, Anthony S Fauci
Pageof 42